The Path Toward a Metabolic Health Revolution–McKinsey report Their new report explores how the advent of GLP-1s has brought the treatment of obesity to the forefront of public attention. Nearly 900 million adults globally are living with obesity, a substantial risk factor for at least 20 diseases/conditions. The rise of GLP-1s is shifting the discussion of obesity from an intractable issue to a treatable medical…
